Raptor Pharmaceuticals Corp (RPTP)

Sector:
HEALTH CARE
Industry:
HEALTH CARE
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
N/A
Employees:
158
9 COMMERCIAL BLVD, SUITE 200, NOVATO, CA, 94949
415-382-1390

• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Operates as a biopharmaceutical company that engages in the acquisition and development of proprietary pharmaceutical compounds for the treatment of Central Nervous System disorders.

View SEC Filings from RPTP instead.

View recent insider trading info

Raptor Pharmaceuticals Corp YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding RPTP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding RPTP

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2016-10-26 by TORREYPINES THERAPEUTICS, INC.
  • 4: filed on 2016-10-26 by TORREYPINES THERAPEUTICS, INC.
  • 4: filed on 2016-10-26 by TORREYPINES THERAPEUTICS, INC.
  • 4: filed on 2016-10-26 by TORREYPINES THERAPEUTICS, INC.
  • 4: filed on 2016-10-26 by TORREYPINES THERAPEUTICS, INC.
  • 4: filed on 2016-10-26 by TORREYPINES THERAPEUTICS, INC.
  • 4: filed on 2016-10-26 by TORREYPINES THERAPEUTICS, INC.
  • 4: filed on 2016-10-26 by TORREYPINES THERAPEUTICS, INC.
  • 4: filed on 2016-10-26 by TORREYPINES THERAPEUTICS, INC.
  • 4: filed on 2016-10-26 by TORREYPINES THERAPEUTICS, INC.

    • Events (8k)

  • 8-K: filed on 2016-10-31:
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-10-25:
    Item 1.02: Termination of a Material Definitive Agreement
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.01: Changes in Control of Registrant
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-10-19:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2016-10-11:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 1.02: Termination of a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-09-12:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-08-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-07-07:
    Item 1.02: Termination of a Material Definitive Agreement
  • 8-K: filed on 2016-05-27:
    Item 8.01: Other Events
  • 8-K: filed on 2016-05-13:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events
  • 8-K: filed on 2016-05-05:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    STARR CHRISTOPHER M

    • Director
    		 No longer subject to file 2016-10-24 0

    FRANKLIN RICHARD L

    • Director
    		 No longer subject to file 2016-10-24 0

    GEMAYEL GEORGES

    • Director
    		 No longer subject to file 2016-10-24 0

    KELTNER LLEW

    • Director
    		 No longer subject to file 2016-10-24 0

    LAPOINTE ANTHONY GREGG

    • Director
    		 No longer subject to file 2016-10-24 0

    SMITH MICHAEL P CHIEF FINANCIAL OFFICER

    • Officer
    		 No longer subject to file 2016-10-24 0

    ANDERSON RAYMOND

    • Director
    		 No longer subject to file 2016-10-24 0

    BRUHN SUZANNE LOUISE

    • Director
    		 No longer subject to file 2016-10-24 0

    SMITH JULIE PRESIDENT AND CEO

    • Officer
    • Director
    		 No longer subject to file 2016-10-24 0

    GOULD ASHLEY C. CHIEF LEGAL OFFICER

    • Officer
    		 No longer subject to file 2016-10-24 0

    HAPPEL DAVID CHIEF COMMERCIAL OFFICER

    • Officer
    		 No longer subject to file 2016-10-24 0

    POLU KRISHNA R CHIEF MEDICAL OFFICER

    • Officer
    		 No longer subject to file 2016-10-24 0

    DALEY THOMAS E CHIEF BUSINESS OFFICER

    • Officer
    		 97,583 2015-06-18 0

    SAGER ERICH

    • Director
    		 4,005 2015-03-05 0

    LANZA FRANK J

    • PRINCIPAL FINANCIAL OFFICER
    		 0 2014-10-23 0

    ERBEZ GEORGIA CHIEF FINANCIAL OFFICER

    • Officer
    		 19,600 2014-05-13 0

    SAMANT VIJAY B

    • Director
    		 70,000 2014-04-07 0

    WALBERT TIMOTHY P

    • Director
    		 52,918 2014-03-13 0

    HYPERION TRADING SEGREGATED PORTFOLIO

    • 10% Owner
    		 No longer subject to file 2013-08-14 0

    RIOUX PATRICE

    • CMO, RAPTOR THERAPEUTICS
    		 No longer subject to file 2012-09-25 0

    TSUCHIMOTO KIM R

    • VICE PRESIDENT FINANCE
    		 No longer subject to file 2012-09-25 0

    ZANKEL TODD CHIEF SCIENTIFIC OFFICER

    • Officer
    		 No longer subject to file 2012-09-25 0

    REICHENBERGER MARC PATRICK

    • VP COMM OPS, RAPTOR THERA
    		 No longer subject to file 2012-09-25 0

    POWELL KATHLENE LINN

    • CQO, RAPTOR THERAPEUTICS
    		 No longer subject to file 2012-09-25 0

    DOUDE VAN TROOSTWIJK HENK J

    • GEN MGR EUROPEAN COMMOP
    		 No longer subject to file 2012-09-25 0

    GIMV NV

    ADVIESBEHEER GIMV LIFE SCIENCES NV

    BIOTECH FONDS VLAANDEREN NV

    • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
    		 No longer subject to file 2009-09-17 0

    ALTA PARTNERS

    DELEAGE JEAN

    ALTA CALIFORNIA PARTNERS II LP

    ALTA CALIFORNIA MANAGEMENT PARTNERS II LLC

    ALTA EMBARCADERO PARTNERS II LLC

    ALTA CALIFORNIA PARTNERS II, L.P. -- NEW POOL

    ALTA CALIFORNIA MANAGEMENT PARTNERS II, LLC -- NEW POOL

    NOHRA GUY P

    JANNEY DANIEL

    GRUENER GARRETT

    • FORMER 10% OWNERNOT DIRECTOR OR 10% OWNERNO LONGER 10% OWNERNO LONGER 10% OWNERNO LONGER 10% OWNERNO LONGER 10% OWNERNO LONGER 10% OWNERNO LONGER 10% OWNERNO LONGER 10% OWNERNO LONGER 10% OWNER
    		 No longer subject to file 2009-09-03 0

    ALTA PARTNERS III, INC.

    ALTA BIOPHARMA PARTNERS III LP

    ALTA BIOPHARMA MANAGEMENT III LLC

    ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG

    ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC

    DELEAGE JEAN

    CHAMPSI FARAH

    PENHOET EDWARD

    HURWITZ EDWARD

    • FORMER 10% OWNERNO LONGER 10% OWNERNO LONGER 10% OWNERNO LONGER 10% OWNERNO LONGER 10% OWNERNOT DIRECTOR OR 10% OWNERNO LONGER 10% OWNERNO LONGER 10% OWNERNO LONGER 10% OWNER
    		 No longer subject to file 2009-09-03 0

    JOHNSON CRAIG A V.P. FINANCE, CFO & SECRETARY

    • Officer
    		 0 2009-02-03 0

    GRAHAM EVELYN A CHIEF EXECUTIVE OFFICER

    • Officer
    		 0 2009-02-03 0

    SCHNEIDER PAUL R V.P. AND GENERAL COUNSEL

    • Officer
    		 0 2009-02-03 0

    RATOFF STEVEN B

    • Director
    		 0 2008-06-19 0

    FISHERMAN JASON S

    • Director
    		 0 2008-06-19 0

    DELEAGE JEAN

    • Director
    		 0 2008-06-19 0

    DAVIS PETER PHD

    • Director
    		 0 2008-06-19 0

    FERRIS STEVEN H

    • Director
    		 0 2008-06-19 0

    KURTZ NEIL M PRESIDENT & CEO

    • Officer
    • Director
    		 22,000 2007-12-06 0

    COMER WILLIAM T

    • Director
    		 175,256 2007-05-18 0

    BENEDEN PATRICK VAN

    • Director
    		 0 2006-10-03 0

    HAUSMAN MARVIN S MD

    • Director
    		 16,500 2006-08-23 0

    SNYDERMAN RALPH

    • Director
    		 16,500 2006-08-23 0

    BRUINSMA GOSSE B PRESIDENT AND CEO

    • Officer
    • Director
    		 122,000 2006-08-23 0

    NEILL SYDNEY COLIN CHIEF FINANCIAL OFFICER

    • Officer
    		 56,400 2006-08-23 0

    CORNACCHIA LOUIS G

    • Director
    		 16,500 2006-08-23 0

    FEUERMAN PAUL GENERAL COUNSEL

    • Officer
    		 56,400 2006-08-23 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments